Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
327.88B
Market cap327.88B
Price-Earnings ratio
35.28
Price-Earnings ratio35.28
Dividend yield
2.68%
Dividend yield2.68%
Average volume
13.39M
Average volume13.39M
High today
$129.97
High today$129.97
Low today
$125.99
Low today$125.99
Open price
$126.18
Open price$126.18
Volume
7.83M
Volume7.83M
52 Week high
$130.29
52 Week high$130.29
52 Week low
$76.66
52 Week low$76.66

Stock Snapshot

As of today, Merck(MRK) shares are valued at $129.97. The company's market cap stands at 327.88B, with a P/E ratio of 35.28 and a dividend yield of 2.68%.

On 2026-07-02, Merck(MRK) stock traded between a low of $125.99 and a high of $129.97. Shares are currently priced at $129.97, which is +3.2% above the low and 0.0% below the high.

Merck(MRK) shares are trading with a volume of 7.83M, against a daily average of 13.39M.

During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $130.29 at its peak.

During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $130.29 at its peak.

MRK News

Simply Wall St 2h
Is Merck’s Expanding Oncology, Vaccine and HIV Portfolio Altering The Investment Case For Merck?

In late June 2026, Merck announced multiple regulatory and clinical milestones, including new KEYTRUDA-based cancer approvals, an expanded CAPVAXIVE vaccine ind...

Is Merck’s Expanding Oncology, Vaccine and HIV Portfolio Altering The Investment Case For Merck?
TipRanks 1d
Merck terminates Phase 2 Alzheimer’s study

Merck (MRK) has terminated a Phase 2 randomized, placebo-controlled study that was intended to evaluate the efficacy and safety of MK-1167 as adjunctive therapy...

Simply Wall St 1d
Merck Wins New Drug Approvals As Its Undervalued Narrative Faces A Fresh Test

Merck (MRK) is back in focus after securing several major drug approvals and positive trial updates, along with an agreement to expand access to its new HIV tre...

Merck Wins New Drug Approvals As Its Undervalued Narrative Faces A Fresh Test

Analyst ratings

67%

of 30 ratings
Buy
66.7%
Hold
26.7%
Sell
6.7%

More MRK News

TipRanks 3d
House committee opens probe into Merck, AbbVie China drug trials, Reuters says

A bipartisan group of U.S. lawmakers has opened national security investigations into whether drugmakers Merck (MRK) and AbbVie (ABBV) have been involved in cli...

Benzinga 3d
Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report

The lawmakers are seeking details about the companies’ clinical trial operations, data protection measures and due diligence practices at research sites across...

Merck, AbbVie Hit With Congressional Probe Over China Drug Trials: Report
Simply Wall St 3d
Broadcom Stock And Two AI Automation Picks Backed By Cash Flow

Global inflation trends, uneven central bank policies, and shifting energy costs are creating a market where headline noise can obscure quieter opportunities. W...

Broadcom Stock And Two AI Automation Picks Backed By Cash Flow
Nasdaq 5d
The Smartest Dividend Stocks to Buy With $5,000 Right Now

When a company earns a profit, it can pay a portion to shareholders as dividends. That's a nice reward for shareholders, providing regular income. However, it's...

The Smartest Dividend Stocks to Buy With $5,000 Right Now
Benzinga 7d
Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’

Qualcomm outlined the acceleration of its diversification strategy at its 2026 Investor Day on June 24. In connection with the event, the semiconductor company...

Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.